Abstract |
Identification of safe and effective adjuvants remains an urgent need for the development of inactivated influenza vaccines for mucosal administration. Here, we used a murine challenge model to evaluate the adjuvant activity of GPI-0100, a saponin-derived adjuvant, on influenza subunit vaccine administered via the intranasal or the intrapulmonary route. Balb/c mice were immunized with 1 µg A/PR/8 (H1N1) subunit antigen alone or in combination with varying doses of GPI-0100. The addition of GPI-0100 was required for induction of mucosal and systemic antibody responses to intranasally administered influenza vaccine and significantly enhanced the immunogenicity of vaccine administered via the intrapulmonary route. Remarkably, GPI-0100-adjuvanted influenza vaccine given at a low dose of 2×1 µg either in the nares or directly into the lungs provided complete protection against homologous influenza virus infection.
|
Authors | Heng Liu, Harshad P Patil, Jacqueline de Vries-Idema, Jan Wilschut, Anke Huckriede |
Journal | PloS one
(PLoS One)
Vol. 7
Issue 12
Pg. e52135
( 2012)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23284901
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adjuvants, Immunologic
- Antibodies, Viral
- GPI0100
- Immunoglobulin A, Secretory
- Immunoglobulin G
- Influenza Vaccines
- Saponins
- Vaccines, Subunit
|
Topics |
- Adjuvants, Immunologic
- Administration, Intranasal
- Animals
- Antibodies, Viral
(blood, immunology)
- Female
- Immunoglobulin A, Secretory
(immunology)
- Immunoglobulin G
(blood, immunology)
- Influenza A Virus, H1N1 Subtype
(immunology)
- Influenza Vaccines
(administration & dosage, immunology)
- Lung
(immunology, pathology, virology)
- Mice
- Mucous Membrane
(immunology)
- Orthomyxoviridae Infections
(prevention & control, virology)
- Saponins
(immunology)
- T-Lymphocytes, Helper-Inducer
(immunology)
- Vaccines, Subunit
|